Initial in vivo experience on Xeltis’ restorative aortic valve will feature as one of the highest peer-reviewed oral abstracts of TCT 2018. Professor Christian Spaulding, Chief, Interventional Cardiology, European Hospital Georges Pompidou, Paris (F), will present long-term pre-clinical on Xeltis’ aortic valve on Saturday, 22 September at 9:30am in Room 29A-B, Upper Level

Professor Spaulding will also provide an overview on Xeltis’ aortic valve replacement therapy as part of the Innovation Sessions on Friday, 21 September. (Room 29A-B, Upper Level)

Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest educational meeting specializing in interventional cardiovascular medicine. This year’s edition will take place September 21-25 in Sand Diego, California (USA).